119 related articles for article (PubMed ID: 5117929)
21. [Sympathetic-adrenal system in Itsenko-Cushing's disease].
Bol'shakova TD; Molchanova GS
Lab Delo; 1982; (8):451-4. PubMed ID: 6182361
[No Abstract] [Full Text] [Related]
22. [The functional condition of blood-brain barrier in Itsenko-Cushing's disease and diencephalic syndrome of Itsenko-Cushing's disease].
Gincherman EZ; Balakhovskaia MI
Probl Endokrinol (Mosk); 1968; 14(4):43-8. PubMed ID: 5734178
[No Abstract] [Full Text] [Related]
23. [State of coronary arteries in Cushing's syndrome].
Zingerman LS; Kilinskiĭ EL
Probl Endokrinol (Mosk); 1968; 14(2):60-1. PubMed ID: 5736636
[No Abstract] [Full Text] [Related]
24. [Functional exploration of the adrenal cortex in Cushing's syndrome: behavior of the free plasma 17-hydroxycorticoids].
Lampertico M; Gelli D; Badoni M; Silvestrini F
Folia Endocrinol; 1965 Oct; 18(5):457-67. PubMed ID: 5899012
[No Abstract] [Full Text] [Related]
25. [On focal lesions of the myocardium in Itsenko-Cushing's disease (electrokymographic study)].
Kilinskiĭ EL; Bukhman AI
Kardiologiia; 1967 Mar; 7(3):103-6. PubMed ID: 5604590
[No Abstract] [Full Text] [Related]
26. Blood pressure responses to phenylephrine infusions in subjects with Cushing's syndrome.
McKnight JA; Rooney DP; Whitehead H; Atkinson AB
J Hum Hypertens; 1995 Oct; 9(10):855-8. PubMed ID: 8576903
[TBL] [Abstract][Full Text] [Related]
27. [Corticoadrenal pathology in Cushing's syndrome].
Simionescu N
Stud Cercet Endocrinol; 1968; 19(2):93-101. PubMed ID: 5669248
[No Abstract] [Full Text] [Related]
28. [Arterial hypertension in Cushing's disease: the 24-hour pressure profile without and during treatment with beta-blockers or cyproheptadine].
Prattichizzo FA
G Ital Cardiol; 1994 May; 24(5):533-8. PubMed ID: 7915698
[TBL] [Abstract][Full Text] [Related]
29. [Itsenko-Cushing's disease].
Granovskaia-Tsvetkova AM; Kechker GL
Feldsher Akush; 1984 Aug; 49(8):24-8. PubMed ID: 6567532
[No Abstract] [Full Text] [Related]
30. Markers of vascular function in hypertension due to Cushing's syndrome.
Zacharieva S; Atanassova I; Nachev E; Orbetzova M; Kirilov G; Kalinov K; Shigarminova R
Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437
[TBL] [Abstract][Full Text] [Related]
31. [Functional state of the myocardium in chronic nonspecific diseases of the lungs].
Ivanova NA; Palanova LN
Vrach Delo; 1971 May; 5():49-52. PubMed ID: 5159480
[No Abstract] [Full Text] [Related]
32. Cardiotomy and ventricular function.
Benzing G; Baker RA; Stockert J; DeForest D; Kaplan S
J Thorac Cardiovasc Surg; 1967 Mar; 53(3):303-11. PubMed ID: 6019141
[No Abstract] [Full Text] [Related]
33. The dispersion quotients: a new approach for evaluating the blood pressure profile in essential versus Cushing's syndrome hypertensive patients.
Gimenez J; Stiefel P; Miranda ML; Leal-Cerro A; Muñiz O; Pamies E; Martin-Sanz MV; Villar J; Carneado J
Ann N Y Acad Sci; 1996 Aug; 783():321-3. PubMed ID: 8853656
[No Abstract] [Full Text] [Related]
34. Pharmacological treatment of hypercortisolism.
Shalet S; Mukherjee A
Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):234-8. PubMed ID: 18438170
[TBL] [Abstract][Full Text] [Related]
35. Corticosteroid release and synthesis in vitro by adrenal slices from patients with Cushing's syndrome.
MULROW PJ; COHN GL
J Clin Invest; 1961 Jul; 40(7):1250-62. PubMed ID: 13726755
[No Abstract] [Full Text] [Related]
36. [The value of several steroid chemical tests in the diagnosis of Cushing's syndrome].
Vingerhoeds AC; Thijssen JH; Kinderen PJ der ; Schwarz F
Ned Tijdschr Geneeskd; 1969 Jul; 113(27):1185-92. PubMed ID: 5792446
[No Abstract] [Full Text] [Related]
37. [Hypertension and Cushing's disease].
Luton JP; Vidal-Trecan G; Mouveroux F; Bricaire H
Ann Med Interne (Paris); 1983; 134(3):203-8. PubMed ID: 6625411
[TBL] [Abstract][Full Text] [Related]
38. An attempt to inhibit synthesis of corticosteroid hormones by means of diethylstilboestrol in a case of Cushing's syndrome. Preliminary report.
KOVACIC N
Acta Med Scand; 1959 Aug; 164():455-61. PubMed ID: 14411382
[No Abstract] [Full Text] [Related]
39. Cushing's syndrome from Klack's solution.
Lankford HV
Endocr Pract; 2000; 6(6):456-8. PubMed ID: 11155219
[TBL] [Abstract][Full Text] [Related]
40. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
